PolyNovo (ASX:PNV) said Chief Financial Officer Jan Gielen will step down to take up the CFO role at Vitrafy Life Sciences (ASX:VFY), effective Jan. 15, 2027, according to a Tuesday Australian bourse filing.
The company has engaged an external firm to appoint an interim CFO, while initiating a comprehensive search for a permanent successor, the filing added.
PolyNovo's shares fell around 2% in recent Tuesday trade, while Vitrafy Life Sciences gained 1%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments